Akari Therapeutics (AKTX) announced the appointment of Abizer Gaslightwala as President and Chief Executive Officer, CEO, effective April 21, ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a ...

THREE of the four lower-seeded PVL quarterfinalists pulled the upset rug from under their higher-seeded opponents during their respective playoff openers. One more win and the Thunderbelles become ...

EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...

After hours: March 20 at 7:08:47 PM EDT Loading Chart for AKTX ...

IPC Indice de Precios Y Cotizaciones 53,060.76 287.44 0.54% ...